Diquafosol tetrasodium elicits total cholesterol release from rabbit meibomian gland cells via P2Y2 purinergic receptor signalling
Abstract Diquafosol tetrasodium (DQS), a purinergic P2Y2 receptor agonist, stimulates secretion of both water and mucins from the conjunctiva into tears. Hence, DQS-containing eye drops have been approved as a therapeutic option for dry eye disease in some Asian countries, including Japan. Recent cl...
Guardado en:
Autores principales: | Ken-ichi Endo, Asuka Sakamoto, Koushi Fujisawa |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cb9a6926715c4b78aae732a9385543d6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Effect of topical 3% diquafosol sodium on eyes with dry eye disease and meibomian gland dysfunction
por: Amano S, et al.
Publicado: (2017) -
Tear film lipid layer increase after diquafosol instillation in dry eye patients with meibomian gland dysfunction: a randomized clinical study
por: Shima Fukuoka, et al.
Publicado: (2019) -
Lash Impaction in Meibomian Gland Orifice
por: Mansour AM, et al.
Publicado: (2020) -
Real-world assessment of diquafosol in dry eye patients with risk factors such as contact lens, meibomian gland dysfunction, and conjunctivochalasis: subgroup analysis from a prospective observational study
por: Yamaguchi M, et al.
Publicado: (2015) -
Emerging treatment options for meibomian gland dysfunction
por: Qiao J, et al.
Publicado: (2013)